Dr. Daniel Drucker pictured in his laboratory at the Lunenfeld-Tanenbaum Research Institute in Toronto (IMAGE)

Lunenfeld-Tanenbaum Research Institute

Dr. Daniel Drucker pictured in his laboratory at the Lunenfeld-Tanenbaum Research Institute in Toronto

Caption

A pioneer in GLP-1 biology Dr. Daniel Drucker has dedicated his career to understanding how the GLP-1 hormone, and the therapies derived from it, function in the body. His early discovery that GLP-1 stimulates insulin secretion in a glucose-dependent manner paved the way for today's widely popular medications for type 2 diabetes and obesity. Dr. Drucker's ongoing research continues to shine light on the less understood aspects of GLP-1 biology including its effects on the liver and in regulating inflammation.

Credit

Colin Dewar, Sinai Health

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.